Innoviva (INVA) EBT Margin Growth (3y) (2014 - 2026)
Innoviva (INVA) EBT Margin Growth (3y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
49,756.00 |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
441.00 |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Innoviva |
1.69 Bn |
1.08 Bn |
75.83 Mn |
-492,898.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-492,898.00 |
| Dec 31, 2025 |
-29,133.00 |
| Sep 30, 2025 |
-2.19 Mn |
| Jun 30, 2025 |
-101,603.00 |
| Mar 31, 2025 |
-366,150.00 |
| Dec 31, 2024 |
-24,183.00 |
| Sep 30, 2024 |
-11,822.00 |
| Jun 30, 2024 |
-1.17 Mn |
| Mar 31, 2024 |
-747,052.00 |
| Dec 31, 2023 |
-1.84 Mn |
| Sep 30, 2023 |
7,087.00 |
| Jun 30, 2023 |
44,273.00 |
| Mar 31, 2023 |
504,774.00 |
| Dec 31, 2022 |
-107,517.00 |
| Sep 30, 2022 |
2.19 Mn |
| Jun 30, 2022 |
100,030.00 |
| Mar 31, 2022 |
353,002.00 |
| Dec 31, 2021 |
-70,312.00 |
| Sep 30, 2021 |
4,453.00 |
| Jun 30, 2021 |
1.16 Mn |
